Bacterial Spectrum of Spontaneously Ruptured Otitis Media in a 7-Year, Longitudinal, Multicenter, Epidemiological Cross-Sectional Study in Germany
We analyzed middle ear fluid (MEF) and nasopharyngeal swabs (NPS) from spontaneously ruptured acute otitis media (AOM) cases occurring in children under 5 years in Germany. The aim of the study was the assessment of disease burden and bacterial etiology in the era of routine pneumococcal vaccination. Furthermore, we aimed to compare isolates from MEF with isolates from NPS and to analyze the Streptococcus pneumoniae serotype distribution. We analyzed MEF and NPS samples in children 2 months to 5 years for vaccination status, frequency of bacterial strains, serotype/emm-type distribution of S. pneumoniae, Haemophilus influenzae, and Streptococcus pyogenes; and intraindividual correlation between MEF and NPS. From 2008 to 2014, MEF samples were collected from 2,138 subjects of which 2,001 (93.6%) also provided an NPS sample. In 851 of 2,138 MEF samples (39.8%), we identified organisms with confirmed pathogenic potential—S. pyogenes: 315 (14.7%), S. pneumoniae: 170 (8.0%), Staphylococcus aureus: 168 (7.9%), H. influenzae: 133 (6.2%), and Moraxella catarrhalis. Among NPS samples, 1,018 (50.9%) contained S. pneumoniae, 775 (38.7%) H. influenzae, 648 (32.4%) M. catarrhalis, and 344 (17.2%) S. pyogenes. Over the seven study years, the number of AOM patients steadily decreased, while the recruiting base remained constant. S. pneumoniae MEF isolates decreased by 86%, with serotype 3 being the most prevalent (25.7–42.9%). PCV13-non-PCV7-non-3 serotypes reduced to 0%. Among NPS, PCV7 serotypes decreased from 14.1 to 3.7%, PCV10: 17.6 to 3.7%, and PCV13: 55.3 to 25.7%. PCV13-non-PCV7-non-3 serotypes increased in the first 3 years of the study (17.1–22.9%), then decreased to 4.6% in year 7. Non-typeable H. influenzae reduced from 87.1 to 41.7% in MEF and from 91.4 to 54.2% in NPS. MEF and NPS isolates from the same subject were identical for 91.9% of S. pneumoniae, 99.0% of S. pyogenes, and 83.3% of H. influenzae. Among PCV7-vaccinated children, 5.6% had a PCV7 vaccine type in the MEF sample, and among PCV13-vaccinated children, 51.7% had a PCV13 serotype. Among non-vaccinated children, the percentages were 14.8 and 70.4. Pneumococcal conjugate vaccination has impacted the prevalence and etiology of spontaneously ruptured otitis media among children in Germany. Overall case numbers and pneumococcal vaccine type cases have strongly decreased.
We thank Dr. Andreas Itzek for critically reading the manuscript and numerous valuable remarks. We sincerely thank all actively participating study sites (Supplemental Material 1).
Funding. This observational study was supported by Pfizer. SP was supported by NIH grant 2T32AI007210-36A1 for part of this project.
- 1. Adam D. Global antibiotic resistance in Streptococcus pneumoniae. J Antimicrob Chemother. (2002) (Suppl. 50) 1:1–5. 10.1093/jac/dkf801  [
- 2. American Academy of Family Physicians, American Academy of Otolaryngology-Head and Neck Surgery and American Academy of Pediatrics Subcommittee on Otitis Media With Effusion . Otitis media with effusion. Pediatrics. (2004) 113:1412–29. 10.1542/peds.113.5.1412  [
- 3. Stamboulidis K, Chatzaki D, Poulakou G, Ioannidou S, Lebessi E, Katsarolis I, et al. . The impact of the heptavalent pneumococcal conjugate vaccine on the epidemiology of acute otitis media complicated by otorrhea. Pediatr Infect Dis J. (2011) 30:551–5. 10.1097/INF.0b013e31821038d9  [
- 4. Bluestone CD, Klein JO. Otitis Media in Infants and Children. 2nd ed. Philadelphia, PA: BC Decker, Inc. (1995).
- 5. Obaro SK, Monteil MA, Henderson DC. The pneumococcal problem. BMJ. (1996) 312:1521–5. 10.1136/bmj.312.7045.1521 ] [
- 6. Fletcher MA, Fritzell B. Brief review of the clinical effectiveness of PREVENAR against otitis media. Vaccine. (2007) 25:2507–2512. 10.1016/j.vaccine.2006.09.027  [
- 7. Robert Koch Institut . Empfehlungen der Ständigen Impfkommission (STIKO) am RKI (Stand Juli 2006): Begründungen zur allgemeinen Empfehlung der Impfung gegen Pneumokokken- und Meningokokken im Säuglings- und Kindesalter. Epidemiologisches Bulletin (2006). P. 255–60.
- 8. Robert Koch Institut . Mitteilung der STIKO zur Impfung gegen invasive Pneumokokken-Infektionen bei Kindern unter 24 Monaten, bei denen die Impfserie mit dem konjugierten 7-valenten Impfstoff begonnen wurde. Vol. 49. Epidemiologisches Bulletin (2009). p. 507.
- 9. Theidel U, Braem A, Ruckinger S. [Determination of vaccination quotas for pneumococcal conjugate vaccine in children on the basis of routine data of the statutory health insurance]. Gesundheitswesen. (2013) 75:309–16. 10.1055/s-0032-1321747  [
- 10. Butler JC, Breiman RF, Lipman HB, Hofmann J, Facklam RR. Serotype distribution of Streptococcus pneumoniae infections among preschool children in the United States, 1978-1994: implications for development of a conjugate vaccine. J Infect Dis. (1995) 171:885–9. 10.1093/infdis/171.4.885  [
- 11. Block SL, Hedrick J, Harrison CJ, Tyler R, Smith A, Findlay R, et al. . Pneumococcal serotypes from acute otitis media in rural Kentucky. Pediatr Infect Dis J. (2002) 21:859–65. 10.1097/00006454-200209000-00015  [
- 12. Black S, Shinefield H, Fireman B, Lewis E, Ray P, Hansen JR, et al. . Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group. Pediatr Infect Dis J. (2000) 19:187–95. 10.1097/00006454-200003000-00003  [
- 13. Dagan R, Fraser D. Conjugate pneumococcal vaccine and antibiotic-resistant Streptococcus pneumoniae: herd immmunity and reduction of otitis morbidity [In Process Citation]. Pediatr Infect Dis J. (2000) 19(Suppl. 5):S79–87; discussion: S88. 10.1097/00006454-200005001-00012  [
- 14. Eskola J, Kilpi T, Palmu A, Jokinen J, Haapakoski J, Herva E, et al. . Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N Engl J Med. (2001) 344:403–9. 10.1056/NEJM200102083440602  [
- 15. Fireman B, Black SB, Shinefield HR, Lee J, Lewis E, Ray P. Impact of the pneumococcal conjugate vaccine on otitis media. Pediatr Infect Dis J. (2003) 22:10–16. 10.1097/00006454-200301000-00006  [
- 16. Obaro SK, Adegbola RA, Banya WA, Greenwood BM. Carriage of pneumococci after pneumococcal vaccination. Lancet. (1996) 348:271–2. 10.1016/S0140-6736(05)65585-7  [
- 17. van der Linden M, Imöhl M, Busse A, Rose M, Adam D. Bacterial spectrum of spontaneously ruptured otitis media in the era of pneumococcal conjugate vaccination in Germany. Eur J Pediatr. (2015) 174:355–64. 10.1007/s00431-014-2409-0  [
- 18. Podbielski A, Melzer B, Lütticken R. Application of the polymerase chain reaction to study the M protein(-like) gene family in beta-hemolytic streptococci. Med Microbiol Immunol. (1991) 180:213–27. 10.1007/BF00215250  [
- 19. Heinz G, Schemper M. A solution to the problem of separation in logistic regression. Stat Med. (2002) 21:2409–19. 10.1002/sim.1047  [
- 20. van der Linden M, Reinert RR. Serotype distribution in pneumococcal acute otitis media with ruptured tympanic membrane or sepsis in Germany. Eur J Clin Microbiol Infect Dis. (2010) 29:749–54. 10.1007/s10096-010-0945-8  [
- 21. Dagan R, Pelton S, Bakaletz L, Cohen R. Prevention of early episodes of otitis media by pneumococcal vaccines might reduce progression to complex disease. Lancet Infect Dis. (2016) 16:480–92. 10.1016/S1473-3099(15)00549-6  [
- 22. Ben-Shimol S, Givon-Lavi N, Leibovitz E, Raiz S, Greenberg D, Dagan R. Near-elimination of otitis media caused by 13-valent pneumococcal conjugate vaccine (PCV) serotypes in southern Israel shortly after sequential introduction of 7-valent/13-valent PCV. Clin Infect Dis. (2014) 59:1724–32. 10.1093/cid/ciu683  [
- 23. Nokso-Koivisto J, Marom T, Chonmaitree T. Importance of viruses in acute otitis media. Curr Opin Pediatr. (2015) 27:110–5. 10.1097/MOP.0000000000000184 ] [
- 24. Ngo CC, Massa HM, Thornton RB, Cripps AW. Predominant bacteria detected from the middle ear fluid of children experiencing otitis media: a systematic review. PLoS ONE. (2016) 11:e0150949. 10.1371/journal.pone.0150949 ] [
- 25. Gorska-Kot A, Greenberg D, Gastol K, Zielinski A, Givon-Lavi N. Characterization of acute otitis media otopathogens before the introduction of the pneumococcal conjugated vaccine into the national immunization program in Poland. Int J Pediatr Otorhinolaryngol. (2019) 127:109666. 10.1016/j.ijporl.2019.109666  [
- 26. Levy C, Varon E, Ouldali N, Wollner A, Thollot F, Corrard F, et al. . Bacterial causes of otitis media with spontaneous perforation of the tympanic membrane in the era of 13 valent pneumococcal conjugate vaccine. PLoS ONE. (2019) 14:e0211712. 10.1371/journal.pone.0211712 ] [
- 27. Sawada S, Okutani F, Kobayashi T. Comprehensive detection of respiratory bacterial and viral pathogens in the middle ear fluid and nasopharynx of pediatric patients with acute otitis media. Pediatr Infect Dis J. (2019) 38:1199–203. 10.1097/INF.0000000000002486  [
- 28. Kakuta R, Yano H, Hidaka H, Miyazaki H, Irimada M, Oda K, et al. . Severe acute otitis media caused by mucoid Streptococcus pyogenes in a previously healthy adult. Tohoku J Exp Med. (2014) 232:301–4. 10.1620/tjem.232.301  [
- 29. Marchisio P, Esposito S, Picca M, Baggi E, Terranova L, Orenti A, et al. . Prospective evaluation of the aetiology of acute otitis media with spontaneous tympanic membrane perforation. Clin Microbiol Infect. (2017) 23:486.e1–e6. 10.1016/j.cmi.2017.01.010  [
- 30. Pichichero M, Kaur R, Scott DA, Gruber WC, Trammel J, Almudevar A, et al. . Effectiveness of 13-valent pneumococcal conjugate vaccination for protection against acute otitis media caused by Streptococcus pneumoniae in healthy young children: a prospective observational study. Lancent Child Adolesc Health. (2018) 2:561–8. 10.1016/S2352-4642(18)30168-8  [
- 31. Rieck T, Feig M, Eckmanns T, Benzler J, Siedler A, Wichmann O. Vaccination coverage among children in Germany estimated by analysis of health insurance claims data. Hum Vaccin Immunother. (2014) 10:476–84. 10.4161/hv.26986 ] [
- 32. Konrad P, Hufnagel M, Berner R, Toepfner N. Long-term, single-center surveillance of non-invasive group A streptococcal (GAS) infections, emm types and emm clusters. Eur J Clin Microbiol Infect Dis. (2020) 39:273–80. 10.1007/s10096-019-03719-4  [
- 33. Simell B, Auranen K, Kayhty H, Goldblatt D, Dagan R, O'Brien KL, et al. . The fundamental link between pneumococcal carriage and disease. Expert Rev Vaccines. (2012) 11:841–55. 10.1586/erv.12.53  [
- 34. Zhang Q, Finn A. Mucosal immunology of vaccines against pathogenic nasopharyngeal bacteria. J Clin Pathol. (2004) 57:1015–21. 10.1136/jcp.2004.016253 ] [
- 35. Rebagliato M. Validation of self reported smoking. J Epidemiol Commun Health. (2002) 56:163–4. 10.1136/jech.56.3.163 ] [
- 36. Shipton D, Tappin DM, Vadiveloo T, Crossley JA, Aitken DA, Chalmers J. Reliability of self reported smoking status by pregnant women for estimating smoking prevalence: a retrospective, cross sectional study. BMJ. (2009) 339:b4347. 10.1136/bmj.b4347 ] [
- 37. Baraibar R. Incidence and risk factors of acute otitis media in children. Clin Microbiol Infect. (1997) 3(Suppl. 3):S13–22. 10.1016/S1198-743X(14)64947-8  [
- 38. Shimada J, Yamanaka N, Hotomi M, Suzumoto M, Sakai A, Ubukata K, et al. . Household transmission of Streptococcus pneumoniae among siblings with acute otitis media. J Clin Microbiol. (2002) 40:1851–3. 10.1128/JCM.40.5.1851-1853.2002 ] [
- 39. Greenberg D, Hoffman S, Leibovitz E, Dagan R. Acute otitis media in children: association with day care centers–antibacterial resistance, treatment, and prevention. Paediatr Drugs. (2008) 10:75–83. 10.2165/00148581-200810020-00002  [
- 40. Chen KK, Huang DT, Chou LT, Nieh HP, Fu RH, Chang CJ. Childhood otitis media: relationship with daycare attendance, harsh parenting, and maternal mental health. PLoS ONE. (2019) 14:e0219684. 10.1371/journal.pone.0219684 ] [